June 18,The thesis defense meeting of Dr. Tang Zan, a postdoctoral fellow jointly trained by the Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences and Shenzhen Beike Biotechnology Co., Ltd., was held at Beike Biotech. Expert leaders such as Ding Jian, professor of the School of Life Sciences of Xi’an Jiaotong University, Liu Gefei, associate professor of Guangdong Food and Drug Vocational College, Hu Yong, associate researcher of the Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Dr. Hu Xiang, chairman of Shenzhen Beike Biotechnology Co., Ltd., and Dr. Liu Muyun, tutor of the postdoctoral workstation, attended the defense meeting.
At the defense meeting, Dr. Tang Zan reported on the proposal of the research project titled “Using Single Cell Sequencing to Study Mesenchymal Stem Cells in the Treatment of Pulmonary Fibrosis”, and gave a detailed explanation of the project background, current status, research ideas, research methods and innovations. The experts of the review team carefully reviewed Dr. Tang Zan’s proposal report, pointed out the theoretical and practical significance of the topic, and the research difficulties, and put forward constructive opinions and suggestions. inherit; font-family: inherit; vertical-align: baseline;”>The final review panel unanimously approved Dr. Tang Zan’s proposal report.
Dr. Liu Muyun, tutor of the postdoctoral workstation, and Professor Hu Yong, associate researcher of the Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, serve as Dr. Tang Zan’s training mentors. Dr. Liu Muyun introduced the basic situation of the Beike Biological Postdoctoral Workstation to the review panel,As a national high-tech enterprise specializing in the clinical transformation and technical services of biotherapeutic technologies in strategic emerging industries, Beike Biotech has strong scientific research capabilities. We hope that Dr. Tang Zan can make full use of the advantageous resources of the joint training platform between Beike Biotech and Shenzhen Institute of Advanced Technology to conduct research, achieve more high-level research results, and make better achievements in the field of biological sciences.
—— Beike Biology Postdoctoral Innovation Practice Base——
Beike Biotechnology was approved by the Shenzhen Municipal Human Resources and Social Security Bureau to establish a postdoctoral innovation practice base in 2013. It is one of the 27 “Postdoctoral Innovation Practice Base” units awarded by Shenzhen that year.
Shenzhen’s postdoctoral innovation practice base began in 1995. The main body of the establishment units is high-tech enterprises, and leading enterprises in various fields are selected. As a leader in subdivided fields, Beike Biotech has built a postdoctoral innovation practice base in the field of cells, demonstrating our scientific research level and ability to transform innovative scientific and technological achievements in the field of biological sciences. In the future, we will continue to recruit and train postdoctoral researchers in accordance with relevant policies and requirements, build a bridge between high-tech talents and enterprises, accelerate the transformation and industrialization of high-tech achievements, and achieve a seamless connection between industry, academia, and research.
